FTSE 100
8.084,61
PKT
-20,71
PKT
-0,26
%
Werbung
Analysen zu FTSE 100-Werten
| Datum | Rating | Analyst | |
|---|---|---|---|
| 13.09.23 | BP Outperform | RBC Capital Markets | |
| 13.09.23 | HSBC Buy | Goldman Sachs Group Inc. | |
| 13.09.23 | RELX Overweight | JP Morgan Chase & Co. | |
| 12.09.23 | easyJet Market-Perform | Bernstein Research | |
| 12.09.23 | International Consolidated Airlines Outperform | Bernstein Research | |
| 12.09.23 | BP Overweight | Barclays Capital | |
| 12.09.23 | Prudential Buy | UBS AG | |
| 12.09.23 | GSK Buy | Deutsche Bank AG | |
| 12.09.23 | Rolls-Royce Buy | UBS AG | |
| 12.09.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 12.09.23 | Barclays Overweight | JP Morgan Chase & Co. | |
| 11.09.23 | AstraZeneca Overweight | Barclays Capital | |
| 11.09.23 | WPP 2012 Hold | Deutsche Bank AG | |
| 11.09.23 | BT Group Hold | Deutsche Bank AG | |
| 11.09.23 | National Grid Outperform | RBC Capital Markets | |
| 11.09.23 | AstraZeneca Buy | UBS AG | |
| 11.09.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 08.09.23 | RELX Buy | UBS AG | |
| 08.09.23 | GSK Buy | Deutsche Bank AG | |
| 08.09.23 | Diageo Sell | Deutsche Bank AG | |
| 08.09.23 | BP Neutral | JP Morgan Chase & Co. | |
| 08.09.23 | GSK Underweight | JP Morgan Chase & Co. | |
| 08.09.23 | RELX Equal Weight | Barclays Capital | |
| 07.09.23 | Diageo Underperform | RBC Capital Markets | |
| 07.09.23 | Rolls-Royce Neutral | JP Morgan Chase & Co. | |
| 06.09.23 | Reckitt Benckiser Market-Perform | Bernstein Research | |
| 06.09.23 | Unilever Underperform | Bernstein Research | |
| 05.09.23 | AstraZeneca Hold | Deutsche Bank AG | |
| 05.09.23 | GSK Buy | Deutsche Bank AG | |
| 05.09.23 | AstraZeneca Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
| 04.09.23 | GSK Equal Weight | Barclays Capital | |
| 01.09.23 | BP Outperform | RBC Capital Markets | |
| 01.09.23 | Unilever Underweight | JP Morgan Chase & Co. | |
| 01.09.23 | Reckitt Benckiser Overweight | JP Morgan Chase & Co. | |
| 30.08.23 | Anglo American Overweight | Barclays Capital | |
| 30.08.23 | Shell (ex Royal Dutch Shell) Outperform | RBC Capital Markets | |
| 29.08.23 | AstraZeneca Overweight | JP Morgan Chase & Co. | |
| 29.08.23 | BAT Buy | UBS AG | |
| 29.08.23 | HSBC Neutral | UBS AG | |
| 24.08.23 | Rolls-Royce Buy | UBS AG |
* Die angezeigten Realtime Kurse sind indikativ und nicht die offiziellen Börsenkurse. Die Kursdaten können eventuell vom tatsächlichen Marktpreis abweichen.